Literature DB >> 17482833

Chronic nitrates blunt the effects of not only nitric oxide but also natriuretic peptides in cardiac myocytes.

Tao Tan1, Qihang Zhang, Chukwuma Anyadike, Peter M Scholz, Harvey R Weiss.   

Abstract

Exposure to nitrates causes tachyphylaxis to nitric oxide (NO), which reduces the effects of the second messenger cyclic guanosine-3',-5'-monophosphate (cyclic GMP). We tested the hypothesis that prolonged exposure to NO would also blunt the effects of natriuretic peptides. Cardiac myocytes were isolated from control (N=7) and chronic nitroglycerin (patched, N=7) rabbits. Patched animals received a transdermal nitroglycerin patch (0.3mg/h for 5 days). Myocyte function was determined at baseline, after C-type natriuretic peptide (CNP, 10(-8) and 10(-7)M) or brain natriuretic peptide (BNP, 10(-8) and 10(-7)M) or S-nitroso-N-acetyl-penicilliamine (SNAP, a NO donor, 10(-6) and 10(-5)M) followed by KT5823 (a cyclic GMP protein kinase inhibitor, 10(-6)M). Soluble and particulate guanylyl cyclase activities were measured in vitro and phosphoprotein analysis was performed. In control animals, CNP 10(-8)M (5.14+/-0.5%) and 10(-7)M (4.4+/-0.7%) significantly reduced percentage shortening from baseline (6.1+/-1.6%). KT5823 restored percentage shortening to 4.9+/-0.8%. Similar data were obtained with BNP and SNAP. In patched animals, CNP, BNP, SNAP had no significant effects on percentage shortening. The data on maximal rate of shortening and relaxation were consistent with these results. Guanylyl cyclase activities were not different in the control and patched animals. The myocytes from control and patched animals had similar protein phosphorylation patterns. Our data suggested that in addition to NO, the responses to both natriuretic peptides were downregulated after chronic exposure to nitroglycerin, but these effects were not due to changes in either guanylyl cyclase or cyclic GMP protein kinase, suggesting an altered downstream pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482833      PMCID: PMC2696194          DOI: 10.1016/j.phrs.2007.03.005

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  29 in total

1.  Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.

Authors:  J D Sadoff; P M Scholz; J Tse; H R Weiss
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Effects of C-type natriuretic peptide on rat cardiac contractility.

Authors:  J M Brusq; E Mayoux; L Guigui; J Kirilovsky
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

3.  Cellular signaling with nitric oxide and cyclic GMP.

Authors:  F Murad
Journal:  Braz J Med Biol Res       Date:  1999-11       Impact factor: 2.590

Review 4.  Nitric oxide and promotion of cardiac myocyte apoptosis.

Authors:  Péter Andréka; Thanh Tran; Keith A Webster; Nanette H Bishopric
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

5.  Functional effects of C-type natriuretic peptide and nitric oxide are attenuated in hypertrophic myocytes from pressure-overloaded mouse hearts.

Authors:  Jun Su; Qihang Zhang; Jacob Moalem; James Tse; Peter M Scholz; Harvey R Weiss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-11-18       Impact factor: 4.733

6.  Nitroglycerin-patch induced tolerance is associated with reduced ability of nitroglycerin to increase exhaled nitric oxide.

Authors:  Per Agvald; Linus Hammar; Lars E Gustafsson
Journal:  Vascul Pharmacol       Date:  2005-10-17       Impact factor: 5.773

7.  Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates.

Authors:  Andreas Daiber; Matthias Oelze; Meike Coldewey; Markus Bachschmid; Philip Wenzel; Karsten Sydow; Maria Wendt; Andrei L Kleschyov; Dirk Stalleicken; Volker Ullrich; Alexander Mülsch; Thomas Münzel
Journal:  Mol Pharmacol       Date:  2004-08-26       Impact factor: 4.436

8.  Formation of reactive oxygen species by pentaerithrityltetranitrate and glyceryl trinitrate in vitro and development of nitrate tolerance.

Authors:  S Dikalov; B Fink; M Skatchkov; D Stalleicken; E Bassenge
Journal:  J Pharmacol Exp Ther       Date:  1998-08       Impact factor: 4.030

9.  Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.

Authors:  T Münzel; H Sayegh; B A Freeman; M M Tarpey; D G Harrison
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

Review 10.  Natriuretic peptides and myocardial ischaemia.

Authors:  Gary F Baxter
Journal:  Basic Res Cardiol       Date:  2004-01-23       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.